Roivant Sciences Ltd. has been buying IMVT.
- The buy: Roivant Sciences Ltd., a Director, bought 16,845,010 shares of IMVT on 13 January 2025 — $336,900,200 at $20.00 a share.
- The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
- Filed: 15 January 2025.
Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.
IM
Continue with Google